Cargando…

Clinical performance of the Abbott Panbio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19

SARS-CoV-2 antigen tests used at the point-of-care, such as the Abbott Panbio, have great potential to help combat the COVID-19 pandemic. The Panbio is Health Canada approved for the detection of SARS-CoV-2 in symptomatic individuals within the first 7 days of COVID-19 symptom onset(s). Symptomatic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stokes, William, Berenger, Byron M., Portnoy, Danielle, Scott, Brittney, Szelewicki, Jonas, Singh, Takshveer, Venner, Allison A., Turnbull, LeeAnn, Pabbaraju, Kanti, Shokoples, Sandy, Wong, Anita A., Gill, Kara, Guttridge, Tracy, Proctor, Dustin, Hu, Jia, Tipples, Graham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979467/ https://www.ncbi.nlm.nih.gov/pubmed/33742322 http://dx.doi.org/10.1007/s10096-021-04202-9

Ejemplares similares

Acceptable performance of the Abbott ID NOW among symptomatic individuals with confirmed COVID-19
por: Stokes, William, et al.
Publicado: (2021)

Prospective population-level validation of the Abbott ID NOW severe acute respiratory syndrome coronavirus 2 device implemented in multiple settings for testing asymptomatic and symptomatic individuals
por: Stokes, William, et al.
Publicado: (2023)

Effect of not vortexing nasopharyngeal and throat swabs on SARS-CoV-2 nucleic acid detection: A pilot study
por: Kanji, Jamil N., et al.
Publicado: (2022)

Multicenter Postimplementation Assessment of the Positive Predictive Value of SARS-CoV-2 Antigen-Based Point-of-Care Tests Used for Screening of Asymptomatic Continuing Care Staff
por: Kanji, Jamil N., et al.
Publicado: (2021)

Evolving strategy for an evolving virus: Development of real-time PCR assays for detecting all SARS-CoV-2 variants of concern
por: Pabbaraju, Kanti, et al.
Publicado: (2022)

Precision Response to the Rise of the SARS-CoV-2 B.1.1.7 Variant of Concern by Combining Novel PCR Assays and Genome Sequencing for Rapid Variant Detection and Surveillance
por: Zelyas, Nathan, et al.
Publicado: (2021)

Tracking SARS-CoV-2 Omicron lineages using real-time reverse transcriptase PCR assays and prospective comparison with genome sequencing
por: Zelyas, Nathan, et al.
Publicado: (2023)

Evaluation of the Abbott Panbio(™) COVID-19 antigen detection rapid diagnostic test among healthcare workers in elderly care
por: Eikelenboom-Boskamp, Andrea, et al.
Publicado: (2023)

Performance evaluation of Roche and Abbott Panbio multiplex SARS-CoV-2 and influenza A/B rapid antigen tests
por: Batty, Mitchell, et al.
Publicado: (2023)

A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay
por: Batra, Rahul, et al.
Publicado: (2020)

Evaluation of the Abbott Panbio(TM) COVID-19 Ag rapid antigen test for the detection of SARS-CoV-2 in asymptomatic Canadians
por: Shaw, Julie L V, et al.
Publicado: (2021)

Abbott ID NOW™ COVID-19 assay: do not discard the swab
por: MacDonald, Clayton, et al.
Publicado: (2023)

Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2
por: Ngo Nsoga, Marie Thérèse, et al.
Publicado: (2021)

False negative rate of COVID-19 PCR testing: a discordant testing analysis
por: Kanji, Jamil N., et al.
Publicado: (2021)

Genetic Characterization and Enhanced Surveillance of Ceftriaxone-Resistant Neisseria gonorrhoeae Strain, Alberta, Canada, 2018
por: Berenger, Byron M., et al.
Publicado: (2019)

Real-life validation of the Panbio™ COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection
por: Gremmels, Hendrik, et al.
Publicado: (2020)

Evaluation of the performance of Abbott Panbio™ COVID-19 antigen rapid diagnostic test for the detection of severe acute respiratory syndrome coronavirus 2 at Harar, Eastern Ethiopia
por: Teklemariam, Zelalem, et al.
Publicado: (2023)

Evaluation of the diagnostic performance of PanbioTM Abbott SARS-CoV-2 rapid antigen test for the detection of COVID-19 from suspects attending ALERT center
por: Ashagre, Wondimu, et al.
Publicado: (2022)

Detection of SARS-CoV-2 antibodies after confirmed Omicron BA.1 and presumed BA.4/5 infections using Abbott ARCHITECT and Panbio assays
por: Boler, Michael, et al.
Publicado: (2023)

Comparison of the pain experienced with anterior nasal swabs and nose and throat swabs in children
por: Harwood, Rachel, et al.
Publicado: (2022)

Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic Patients
por: Harrington, Amanda, et al.
Publicado: (2020)

Evaluation of the rapid antigen test Panbio COVID-19 in saliva and nasal swabs in a population-based point-of-care study
por: Agulló, Vanesa, et al.
Publicado: (2021)

Emergence of a Novel Recombinant Norovirus GII.P16-GII.12 Strain Causing Gastroenteritis, Alberta, Canada
por: Pabbaraju, Kanti, et al.
Publicado: (2019)

The Abbott PanBio WHO emergency use listed, rapid, antigen-detecting point-of-care diagnostic test for SARS-CoV-2—Evaluation of the accuracy and ease-of-use
por: Krüger, Lisa J., et al.
Publicado: (2021)

Evaluating addition of self-collected throat swabs to nasal swabs for respiratory virus detection
por: Fisher, Cynthia E., et al.
Publicado: (2019)

An Investigation into a Throat Swab Collection Device for Children
por: Zeng, Rong-fang, et al.
Publicado: (2023)

Development and validation of a multiplex reverse transcriptase-PCR assay for simultaneous testing of influenza A, influenza B and SARS-CoV-2
por: Pabbaraju, Kanti, et al.
Publicado: (2021)

Screening for SARS-CoV-2 infection in asymptomatic individuals using the Panbio COVID-19 antigen rapid test (Abbott) compared with RT-PCR: a prospective cohort study
por: Winkel, Beatrice, et al.
Publicado: (2021)

Comparison of Throat Washings, Nasopharyngeal Swabs and Oropharyngeal Swabs for Detection of SARS-CoV-2
por: Hitzenbichler, Florian, et al.
Publicado: (2021)

Optimal site of throat swab for the isolation of beta-hemolytic streptococci.
por: Kim, S. J.
Publicado: (1993)

Identification of microRNAs in Throat Swab as the Biomarkers for Diagnosis of Influenza
por: Peng, Fang, et al.
Publicado: (2016)

Compendio Abbott.
Publicado: (1953)

Abbott’s at the Top
Publicado: (1909)

Abbott’s Scissors
Publicado: (1883)

Abbott’s Scissors
Publicado: (1884)

One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW™
por: Burnes, Laura E, et al.
Publicado: (2021)

Saliva collected in universal transport media is an effective, simple and high-volume amenable method to detect SARS-CoV-2
por: Berenger, Byron M., et al.
Publicado: (2021)

A cost effective real-time PCR for the detection of adenovirus from viral swabs
por: Al-Siyabi, Turkiya, et al.
Publicado: (2013)

Throat and nasal swabs for molecular detection of respiratory viruses in acute pharyngitis
por: Ali, Mohsin, et al.
Publicado: (2015)

Acinetobacter geminorum sp. nov., isolated from human throat swabs
por: Wolf, Sophia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_futun50fi6u2ndmqnkoa2efihr